Amgen Played Waiting Game Before Agreeing $3.7bn ChemoCentryx Deal

SEC Filings Show Tactical Negotiations

 
• By Andrew McConaghie
Amgen
Amgen first opened talks with ChemoCentryx in early 2020, eventually paying $3.7bn for the company. • Source: Shutterstock

More from Deals

More from Business